Literature DB >> 25122789

The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines.

Christopher D O'Donnell1, Leatrice Vogel1, Yumiko Matsuoka1, Hong Jin2, Kanta Subbarao3.   

Abstract

UNLABELLED: The threat of future influenza pandemics and their potential for rapid spread, morbidity, and mortality has led to the development of pandemic vaccines. We generated seven reassortant pandemic live attenuated influenza vaccines (pLAIVs) with the hemagglutinin (HA) and neuraminidase (NA) genes derived from animal influenza viruses on the backbone of the six internal protein gene segments of the temperature sensitive, cold-adapted (ca) A/Ann Arbor/60 (H2N2) virus (AA/60 ca) of the licensed seasonal LAIV. The pLAIV viruses were moderately to highly restricted in replication in seronegative adults; we sought to determine the biological basis for this restriction. Avian influenza viruses generally replicate at higher temperatures than human influenza viruses and, although they shared the same backbone, the pLAIV viruses had a lower shutoff temperature than seasonal LAIV viruses, suggesting that the HA and NA influence the degree of temperature sensitivity. The pH of HA activation of highly pathogenic avian influenza viruses was greater than human and low-pathogenicity avian influenza viruses, as reported by others. However, pLAIV viruses had a consistently higher pH of HA activation and reduced HA thermostability compared to the corresponding wild-type parental viruses. From studies with single-gene reassortant viruses bearing one gene segment from the AA/60 ca virus in recombinant H5N1 or pH1N1 viruses, we found that the lower HA thermal stability and increased pH of HA activation were associated with the AA/60 M gene. Together, the impaired HA acid and thermal stability and temperature sensitivity likely contributed to the restricted replication of the pLAIV viruses we observed in seronegative adults. IMPORTANCE: There is increasing evidence that the HA stability of influenza viruses depends on the virus strain and host species and that HA stability can influence replication, virulence, and transmission of influenza A viruses in different species. We investigated the HA stability of pandemic live attenuated influenza vaccine (pLAIV) viruses and observed that the pLAIV viruses consistently had a less stable HA than the corresponding wild-type influenza viruses. The reduced HA stability and temperature sensitivity of the pLAIV viruses may account for their restricted replication in clinical trials.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25122789      PMCID: PMC4248896          DOI: 10.1128/JVI.01107-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

Review 1.  Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines.

Authors:  Brian R Murphy; Kathleen Coelingh
Journal:  Viral Immunol       Date:  2002       Impact factor: 2.257

Review 2.  Emerging influenza viruses: past and present.

Authors:  Darwyn Kobasa; Yoshihiro Kawaoka
Journal:  Curr Mol Med       Date:  2005-12       Impact factor: 2.222

Review 3.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

4.  Cold co-extraction of hemagglutinin and matrix M1 protein from influenza virus A by a combination of non-ionic detergents allows for visualization of the raft-like nature of the virus envelope.

Authors:  V Radyukhin; N Fedorova; A Ksenofontov; M Serebryakova; L Baratova
Journal:  Arch Virol       Date:  2008-09-30       Impact factor: 2.574

5.  Variant influenza virus hemagglutinin that induces fusion at elevated pH.

Authors:  R W Doms; M J Gething; J Henneberry; J White; A Helenius
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

6.  Time and temperature dependence of influenza virus membrane fusion at neutral pH.

Authors:  A M Haywood; B P Boyer
Journal:  J Gen Virol       Date:  1986-12       Impact factor: 3.891

7.  Infectious cell entry mechanism of influenza virus.

Authors:  A Yoshimura; K Kuroda; K Kawasaki; S Yamashina; T Maeda; S Ohnishi
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

8.  Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.

Authors:  Amorsolo L Suguitan; Josephine McAuliffe; Kimberly L Mills; Hong Jin; Greg Duke; Bin Lu; Catherine J Luke; Brian Murphy; David E Swayne; George Kemble; Kanta Subbarao
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

Review 9.  Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.

Authors:  Christopher S Ambrose; Catherine Luke; Kathleen Coelingh
Journal:  Influenza Other Respir Viruses       Date:  2008-11       Impact factor: 4.380

10.  Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation.

Authors:  Summer E Galloway; Mark L Reed; Charles J Russell; David A Steinhauer
Journal:  PLoS Pathog       Date:  2013-02-14       Impact factor: 6.823

View more
  19 in total

1.  Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine.

Authors:  Kelly Stefano Cole; Judith M Martin; William T Horne; Chyongchiou J Lin; Mary Patricia Nowalk; John F Alcorn; Richard K Zimmerman
Journal:  Vaccine       Date:  2017-11-11       Impact factor: 3.641

Review 2.  Influenza Hemagglutinin Protein Stability, Activation, and Pandemic Risk.

Authors:  Charles J Russell; Meng Hu; Faten A Okda
Journal:  Trends Microbiol       Date:  2018-04-19       Impact factor: 17.079

3.  Influenza Virus Overcomes Cellular Blocks To Productively Replicate, Impacting Macrophage Function.

Authors:  Shauna A Marvin; Marion Russier; C Theodore Huerta; Charles J Russell; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

4.  Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface.

Authors:  Esmeralda Alvarado-Facundo; Yamei Gao; Rosa María Ribas-Aparicio; Alicia Jiménez-Alberto; Carol D Weiss; Wei Wang
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

5.  Influenza hemagglutinin (HA) stem region mutations that stabilize or destabilize the structure of multiple HA subtypes.

Authors:  Lauren Byrd-Leotis; Summer E Galloway; Evangeline Agbogu; David A Steinhauer
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

6.  A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.

Authors:  Feng Wen; Lei Li; Nan Zhao; Meng-Jung Chiang; Hang Xie; Jim Cooley; Richard Webby; Peng George Wang; Xiu-Feng Wan
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

7.  Molecular requirements for a pandemic influenza virus: An acid-stable hemagglutinin protein.

Authors:  Marion Russier; Guohua Yang; Jerold E Rehg; Sook-San Wong; Heba H Mostafa; Thomas P Fabrizio; Subrata Barman; Scott Krauss; Robert G Webster; Richard J Webby; Charles J Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

Review 8.  Hemagglutinin Stability and Its Impact on Influenza A Virus Infectivity, Pathogenicity, and Transmissibility in Avians, Mice, Swine, Seals, Ferrets, and Humans.

Authors:  Charles J Russell
Journal:  Viruses       Date:  2021-04-24       Impact factor: 5.048

9.  Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.

Authors:  Manjusha Gaglani; Jessica Pruszynski; Kempapura Murthy; Lydia Clipper; Anne Robertson; Michael Reis; Jessie R Chung; Pedro A Piedra; Vasanthi Avadhanula; Mary Patricia Nowalk; Richard K Zimmerman; Michael L Jackson; Lisa A Jackson; Joshua G Petrie; Suzanne E Ohmit; Arnold S Monto; Huong Q McLean; Edward A Belongia; Alicia M Fry; Brendan Flannery
Journal:  J Infect Dis       Date:  2016-01-06       Impact factor: 7.759

10.  2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

Authors:  Richard K Zimmerman; Mary Patricia Nowalk; Jessie Chung; Michael L Jackson; Lisa A Jackson; Joshua G Petrie; Arnold S Monto; Huong Q McLean; Edward A Belongia; Manjusha Gaglani; Kempapura Murthy; Alicia M Fry; Brendan Flannery
Journal:  Clin Infect Dis       Date:  2016-10-04       Impact factor: 20.999

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.